PharVision Advisers’s HP HPQ Stock Holding History

PharVision Advisers’s Portfolio HPQ Stock Details HPQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$233K	Sell	12,118 -6,906	-36%	-$134K	2.36%	1
2025 Q4	$424K	Buy	+19,024	New	+$485K	0.21%	97

Other funds holding HPQ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's HPQ Position: Q1 2026 in Review

PharVision Advisers reduced its HP (HPQ) stake by 36% in Q1 2026, selling an estimated $134K and leaving 12,118 shares worth $233K. The position accounts for 2.36% of the portfolio, ranked #1.

PharVision Advisers first reported a position in HPQ in Q4 2025 and has held it in 2 quarters since. The position peaked at $424K in Q4 2025. 1,028 funds tracked by Wall St. Rank hold HPQ as of Q1 2026.

PharVision Advisers held 12,118 shares of HP worth $233K as of Q1 2026.
PharVision Advisers sold 6,906 HP shares in Q1 2026, an estimated $134K.
HP made up 2.36% of PharVision Advisers's portfolio in Q1 2026, its #1 holding.
PharVision Advisers first reported a position in HP in Q4 2025 and has held it in 2 quarters since.
PharVision Advisers's HP position peaked at $424K in Q4 2025.
1,028 funds tracked by Wall St. Rank held HP as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.